Mark T Iwicki's Net Worth
$5.98 Million
Who is Mark T Iwicki?
Mark T Iwicki has an estimated net worth of $5.98 Million. This is based on reported shares across multiple companies, which include Merus N.V., Pulmatrix, Inc., Aerovate Therapeutics, Inc., Akero Therapeutics, Inc., Kala Pharmaceuticals, Inc., Aimmune Therapeutics, Inc., Third Harmonic Bio, Inc., and SEPRACOR INC /DE/.
SEC CIK
Mark T Iwicki's CIK is 0001415537
Past Insider Trading and Trends
2023 was Mark T Iwicki's most active year for acquiring shares with 13 total transactions. Mark T Iwicki's most active month to acquire stocks was the month of April. 2023 was Mark T Iwicki's most active year for disposing of shares, totalling 15 transactions. Mark T Iwicki's most active month to dispose stocks was the month of September. 2007 saw Mark T Iwicki paying a total of $5,724,700.00 for 230,000 shares, this is the most they've acquired in one year. In 2009 Mark T Iwicki cashed out on 249,665 shares for a total of $3,450,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merus N.V. (MRUS) Snapshot price: $36.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 73.58K |
$7.27 | $534,679.12 | 73.58K |
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pulmatrix, Inc. (PULM) Snapshot price: $1.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 307K |
—
|
—
| 307K |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $20.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2 - Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALA BIO, Inc. (KALA) Snapshot price: $7.1
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.44% | -15.17K |
$4.75 | -$72,048.00 | 263.75K |
Jun 26
| |||
Form 4
| -2.58% | -7.39K |
$6.09 | -$45,017.28 | 278.92K |
May 31
| |||
Form 4
| +3.53% | 9.76K |
$6.73 | -$30,547.47 | 286.31K |
Jan 4
| |||
Form 4
| +135.00% | 158.87K |
—
|
—
| 276.55K |
Jun 22
| |||
Form 4
| +156.02% | 71.72K |
—
|
—
| 117.68K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +929.70% | 41.5K |
$28.54 | -$5,650.92 | 45.97K |
Scheduled
|
Jan 4
| ||
Form 4
| -11.16% | -561.00 |
$6.52 | -$3,657.72 | 4.46K |
Scheduled
|
Oct 26
| ||
Form 4
| -3.08% | -7.97K |
$0.37 | -$2,950.75 | 251.18K |
Scheduled
|
Jun 27
| ||
Form 4
| -3.54% | -9.52K |
$1.30 | -$12,373.40 | 259.16K |
Scheduled
|
Jan 3 - Jan 4
| ||
Form 4
| -9.32% | -27.60K |
$1.80 | -$49,676.40 | 268.68K |
Scheduled
|
Oct 26
| ||
Form 4
| -2.50% | -7.59K |
$5.77 | -$43,771.22 | 296.27K |
Scheduled
|
Jun 28
| ||
Form 4
| +33.35% | 76K |
—
|
—
| 303.86K |
Jan 4
| |||
Form 4
| +359.77% | 178.3K |
—
|
—
| 227.86K |
Oct 26
| |||
Form 4
|
∞
| 49.56K |
—
|
—
| 49.56K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||